Han et al 29 also found that silencing ASF1B suppressed the proliferation of prostate cancer cells and promoted their apoptosis and cell cycle arrest, and this inhibitory effect might be related to the inactivation of the PI3K/Akt pathway. Here, ASF1B is linked to prostate carcinoma.